Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventional, Randomised, Double-blind, Placebo-controlled, Fixed-dose Study of Vortioxetine in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

NCT02327013 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT02327013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02327013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventional, Randomised, Double-blind, Placebo-controlled, Fixed-dose Study of Vortioxetine in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Lead sponsor
H. Lundbeck A/S
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2014
Completion date
September 30, 2016
Enrollment
227 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder